Cadrenal Therapeutics (CVKD) stock: insider trades, news & valuation
Net sellingShare price and insider trades
Cadrenal Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 2 sold $642K of CVKD stock on the open market.
Get emailed when insiders cluster-buy stocks like CVKD
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
CVKD insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | $388K | 22 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | — | 0 | $298K | 13 |
| Q3 2025 | — | 0 | $7K | 2 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Cadrenal Therapeutics, Inc. insiders reported open-market purchases totaling $0, while 2 insiders reported sales totaling $642K. 37 of 37 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jul 1SEC | Quang X PhamCEO, Chair | Sell Plan | 7,40098,589 held (−7%) | $3.03 | $22K | -70.0% | — |
| Jun 26SEC | Quang X PhamCEO, CFO | Sell Plan | 9,029105,989 held (−8%) | $3.05 | $28K | -70.2% | — |
| Jun 26SEC | Quang X PhamCEO, CFO | Sell Plan | 2,127115,018 held (−2%) | $3.00 | $6K | -69.7% | — |
| Jun 24SEC | Quang X PhamCEO, CFO | Sell Plan | 9,167119,422 held (−7%) | $3.55 | $33K | -74.4% | — |
| Jun 24SEC | Quang X PhamCEO, CFO | Sell Plan | 2,277117,145 held (−2%) | $3.20 | $7K | -71.6% | — |
| Jun 18SEC | Quang X PhamCEO, CFO | Sell Plan | 3,613129,102 held (−3%) | $3.18 | $11K | -71.4% | — |
| Jun 18SEC | Quang X PhamCEO, CFO | Sell Plan | 513128,589 held (−0%) | $3.16 | $2K | -71.2% | — |
| Jun 15SEC | Quang X PhamCEO, CFO | Sell Plan | 12,996136,381 held (−9%) | $3.94 | $51K | -76.9% | — |
| Jun 15SEC | Quang X PhamCEO, CFO | Sell Plan | 3,666132,715 held (−3%) | $3.58 | $13K | -74.6% | — |
| Jun 15SEC | Quang X PhamCEO, CFO | Sell Plan | 1,462149,377 held (−1%) | $4.12 | $6K | -77.9% | — |
| Jun 10SEC | Quang X PhamCEO, CFO | Sell Plan | 12,992154,339 held (−8%) | $4.06 | $53K | -77.6% | — |
| Jun 10SEC | Quang X PhamCEO, CFO | Sell Plan | 5,893167,331 held (−3%) | $4.38 | $26K | -79.2% | — |
| Jun 10SEC | Quang X PhamCEO, CFO | Sell Plan | 3,500150,839 held (−2%) | $4.21 | $15K | -78.4% | — |
| Jun 5SEC | Quang X PhamCEO, Chair | Sell Plan | 3,898175,288 held (−2%) | $4.41 | $17K | -79.4% | — |
| Jun 5SEC | Quang X PhamCEO, Chair | Sell Plan | 2,323179,186 held (−1%) | $4.26 | $10K | -78.6% | — |
| Jun 5SEC | Quang X PhamCEO, Chair | Sell Plan | 2,064173,224 held (−1%) | $4.42 | $9K | -79.4% | — |
| Jun 2SEC | Quang X PhamCEO, Chair | Sell Plan | 349181,509 held (−0%) | $4.46 | $2K | -79.6% | — |
| Jun 2SEC | Quang X PhamCEO, Chair | Sell Plan | 303181,858 held (−0%) | $5.01 | $2K | -81.8% | — |
| May 29SEC | Quang X PhamCEO, Chair | Sell Plan | 6,476188,448 held (−3%) | $5.76 | $37K | -84.2% | — |
| May 29SEC | Quang X PhamCEO, Chair | Sell Plan | 3,298185,150 held (−2%) | $5.28 | $17K | -82.8% | — |
| May 29SEC | Quang X PhamCEO, Chair | Sell Plan | 2,989182,161 held (−2%) | $4.93 | $15K | -81.5% | — |
| May 26SEC | Quang X PhamCEO, Chair | Sell Plan | 1,165194,924 held (−1%) | $5.69 | $7K | -84.0% | — |
| Dec 31SEC | Matthew K SzotCFO | Sell Plan | 9,933 | $6.97 | $69K | -86.9% | — |
| Oct 28SEC | Matthew K SzotCFO | Sell Plan | 1,80011,733 held (−13%) | $13.99 | $25K | -93.5% | — |
| Oct 28SEC | Matthew K SzotCFO | Sell Plan | 1,8009,933 held (−15%) | $13.99 | $25K | -93.5% | — |
| Oct 28SEC | Quang X PhamCEO, Chair | Sell Plan | 1,315196,089 held (−1%) | $13.99 | $18K | -93.5% | — |
| Oct 28SEC | Quang X PhamCEO, Chair | Sell Plan | 1,129197,404 held (−1%) | $14.03 | $16K | -93.5% | — |
| Oct 14SEC | Quang X PhamCEO, Chair | Sell Plan | 1,800198,533 held (−1%) | $14.15 | $25K | -93.6% | — |
| Oct 14SEC | Matthew K SzotCFO | Sell Plan | 1,80013,533 held (−12%) | $14.07 | $25K | -93.5% | — |
| Oct 14SEC | Quang X PhamCEO, Chair | Sell Plan | 1,800200,333 held (−1%) | $14.02 | $25K | -93.5% | — |
| Oct 14SEC | Matthew K SzotCFO | Sell Plan | 1,69315,333 held (−10%) | $13.99 | $24K | -93.5% | — |
| Oct 7SEC | Matthew K SzotCFO | Sell Plan | 10717,026 held (−1%) | $13.99 | $1K | -93.5% | — |
| Oct 3SEC | Quang X PhamCEO, Chair | Sell Plan | 500202,133 held (−0%) | $14.13 | $7K | -93.6% | — |
| Oct 1SEC | Matthew K SzotCFO | Sell Plan | 1,70017,133 held (−9%) | $13.99 | $24K | -93.5% | — |
| Oct 1SEC | Quang X PhamCEO, Chair | Sell Plan | 881202,633 held (−0%) | $14.01 | $12K | -93.5% | — |
| Oct 1SEC | Quang X PhamCEO, Chair | Sell Plan | 419203,514 held (−0%) | $14.01 | $6K | -93.5% | — |
| Oct 1SEC | Matthew K SzotCFO | Sell Plan | 10018,833 held (−1%) | $14.00 | $1K | -93.5% | — |
Insiders at Cadrenal Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Quang X PhamCEO, Chair | — | $499K | Jul 1, 2026 | — |
| Matthew K SzotCFO | — | $195K | Dec 31, 2025 | — |
CVKD stock: common questions
Are Cadrenal Therapeutics, Inc. insiders buying CVKD stock?
In the past 12 months, 0 insiders reported open-market purchases of CVKD worth $0.
Are Cadrenal Therapeutics, Inc. insiders selling CVKD stock?
2 insiders reported sales worth $642K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is CVKD's 52-week range?
Over the past year CVKD has traded between $0.91 and $14.19. It last closed at $0.91 on Oct 9, 2026.